Clinical Trials Directory

Trials / Completed

CompletedNCT01929031

Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain

A Single-centre, Double-blind, Randomised, Two-stage, Parallel-group Study to Assess the Efficacy and Safety of the Fixed Dose Combination of Ibuprofen 400 mg and Caffeine 100 mg Versus Ibuprofen 400 mg, Caffeine 100 mg and Placebo in Patients With Postoperative Dental Pain

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
562 (actual)
Sponsor
Boehringer Ingelheim · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to compare the efficacy of a combination product containing ibuprofen 400 mg and caffeine 100 mg versus either ingredient alone as well as placebo for the treatment of post-surgical dental pain over an eight-hour period followed by a single dose of study medication (study stage 1). A secondary objective is to evaluate efficacy of multiple doses of the combination in comparison to ibuprofen alone over a 5-day post-surgical period (study stage 2).

Conditions

Interventions

TypeNameDescription
DRUGibuprofen + caffeineFDC tablet
DRUGibuprofentablet.
DRUGibuprofentablet
DRUGcaffeinetablet
DRUGibuprofen + caffeineFixed Dose Combination (FDC) tablet
DRUGplacebotablet
DRUGplacebotablet
DRUGcaffeinetablet
DRUGibuprofentablet
DRUGibuprofen + caffeineFDC tablet

Timeline

Start date
2013-08-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2013-08-27
Last updated
2016-11-16
Results posted
2016-11-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01929031. Inclusion in this directory is not an endorsement.